Background Brain amyloid deposition and neurofibrillary tangles in Alzheimer’s disease (AD)
are associated with complex neuroinflammatory reactions such as microglial activation …

In Alzheimer's disease (AD), brain lesions are marked by severe neuronal loss and retinal
degeneration was previously mentioned in affected patients. Mild cognitive impairment (MCI) …

OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic has caused major
sanitary crisis worldwide. Half of the world has been placed in quarantine. In France, this large-…

Background Synaptic degeneration is a central pathogenic event in Alzheimer’s disease that
occurs early during the course of disease and correlates with cognitive symptoms. The pre-…

Background The ε4 allele of apolipoprotein E (APOE) gene and increasing age are two of the
most important known risk factors for developing Alzheimer disease (AD). The diagnosis of …

Background Brain lesions in Alzheimer’s disease (AD) are characterized by Aβ accumulation,
neurofibrillary tangles, and synaptic and neuronal vanishing. According to the amyloid …

Biomarker testing is recommended for the accurate and timely diagnosis of Alzheimer's
disease (AD). Using illustrative case narratives we consider how cerebrospinal fluid (CSF) …

Importance Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that
increases in the cerebrospinal fluid (CSF) and blood of individuals with Alzheimer disease (AD). …

Background Amyloid protein precursor (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2)
mutations cause autosomal dominant forms of early-onset Alzheimer disease (AD-EOAD)…

Sleep dysregulation is a feature of dementia but it remains unclear whether sleep duration
prior to old age is associated with dementia incidence. Using data from 7959 participants of …